Keyphrases
Natural Killer Cells
100%
Engager
100%
Cell-mediated
100%
Trispecific
100%
Acute Myeloid Leukemia Cells
100%
CLEC12A
100%
Acute Myeloid Leukemia
57%
TriKE
57%
Leukemic Stem Cells
42%
Disease Relapse
28%
Effective Treatment
14%
Tumor Growth
14%
Humanized
14%
Hematopoietic Stem Cells
14%
Therapeutic Strategies
14%
Conventional Chemotherapy
14%
Cell Survival
14%
Interleukin-15 (IL-15)
14%
Patient-derived
14%
CD16
14%
Cell Killing
14%
Cell Expansion
14%
Leukemia Cell Lines
14%
Tumor Burden
14%
5-year Survival
14%
Clinical Potential
14%
Natural Killer Cell Activity
14%
Heavy Chain
14%
Cell Priming
14%
Myeloid Lineage
14%
ScFv
14%
Single-chain Variable Fragment
14%
Normal Hematopoietic Stem Cells
14%
Off-target Toxicity
14%
Camelid Single-domain Antibodies
14%
Preclinical Animal Models
14%
Immunology and Microbiology
Natural Killer Cell
100%
Myeloid
100%
Leukemia Cell
100%
Stem Cell
42%
Hematopoietic Stem Cell
28%
Lineages
14%
Camelid
14%
Mouse Model
14%
Cell Killing
14%
Cell Activation
14%
Tumor Volume
14%
CD16
14%
Survival Rate
14%
Single-Chain Variable Fragment
14%
Acute Myeloid Leukemia Cell Line
14%
Single-Domain Antibody
14%
Interleukin 15
14%
Heavy Chain
14%